Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.41 USD | +7.97% | +12.18% | -12.73% |
05-09 | Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
05-09 | Transcript : Intellia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.73% | 2.36B | |
+23.65% | 44.96B | |
+1.36% | 42.65B | |
+46.11% | 41.85B | |
-4.27% | 29.04B | |
+11.15% | 26.08B | |
-20.57% | 19.03B | |
+6.92% | 12.75B | |
+28.30% | 12.06B | |
-4.08% | 11.75B |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- Insider Sell: Intellia Therapeutics